Viewing Study NCT04697784



Ignite Creation Date: 2024-05-06 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 1:53 PM
Study NCT ID: NCT04697784
Status: RECRUITING
Last Update Posted: 2023-09-29
First Post: 2020-12-10

Brief Title: Post-Approval Study of the TREO Abdominal Stent-Graft System
Sponsor: Bolton Medical
Organization: Bolton Medical

Study Overview

Official Title: Post-Approval Study of the TREO Abdominal Stent-Graft System P190015 in Patients With Infrarenal Abdominal Aortic and Aorto-iliac Aneurysms
Status: RECRUITING
Status Verified Date: 2023-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TREO PAS
Brief Summary: The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms
Detailed Description: This is a prospective multi-center non-randomized single-arm post-market non-interventional study of treatment with the TREO Abdominal Stent-Graft in subjects with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms The study will include a minimum of 300 subjects treated with the TREO Abdominal Stent-Graft at up to 55 investigational sites in the US

The primary objective is the collection of real world safety and effectiveness outcomes of the TREO Abdominal Stent-Graft System in an all-comers population eligible for the endovascular treatment of AAA in routine clinical practice with emphasis on subjects that experience a device stent-strut or barb fracture

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None